Flavanols and cardiovascular health: Effects on the circulating NO pool in humans

Journal of Cardiovascular Pharmacology

Volumn 47, Issue SUPPL. 2, 2006, Pages

  Balzer, Jan ^a   Heiss, Christian ^b   Schroeter, Hagen ^c   Brouzos, Paris ^a   Kleinbongard, Petra ^a   Matern, Simone ^a   Lauer, Thomas ^a   Rassaf, Tienush ^a   Kelm, Malte ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Circulating NO pool; Endothelial function; Flavanols

Indexed keywords

FLAVONOID; FLAVONOL DERIVATIVE; NITRATE; NITRIC OXIDE; NITRITE;

AEROBIC METABOLISM; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; DIET THERAPY; DRUG ACTIVITY; ENDOTHELIUM; ERYTHROCYTE; EXERCISE; FOOD; FRUIT; HUMAN; NUTRITION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMIC CIRCULATION; VEGETABLE;

ENDOTHELIUM, VASCULAR; ERYTHROCYTES; FLAVONOIDS; HUMANS; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; NITROSO COMPOUNDS;

EID: 33750309649     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200606001-00006     Document Type: Review

References (61)

1. Loscalzo J. Nitric oxide and vascular disease. N Engl J Med. 1995;333:251-253.
2. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002;22:19-34.
3. Holt RR, Schramm DD, Keen CL, et al. Chocolate consumption and platelet function. JAMA. 2002;287:2212-2213.
4. Leikert JF, Räthel TR, Wohlfahrt P, et al. Red wine polphenols enhance endothelial nitritc oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 2002;106:1614-1617.
5. Doyle MP, Hoekstra JW. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J Inorg Biochem. 1981;14:351-358.
6. Gladwin MT, Lancaster Jr JR, Freeman BA, et al. Nitric oxide's reactions with hemoglobin: a view through the SNO-storm. Nat Med. 2003;9:496-500.
7. Gladwin MT, Shelhamer JH, Schechter AN, et al. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci USA. 2000;97:11482-11487.
8. Jia L, Bonaventura C, Bonaventura J, et al. S-nitrosohemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996;380:221-226.
9. Joshi MS, Ferguson Jr TB, Han TH, et al. Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc Natl Acad Sci USA. 2002;99:10341-10346.
10. Rassaf T, Bryan NS, Maloney RE, et al. NO adducts in mammalian red blood cells: too much or too little? Nat Med. 2003;9:481-482.
11. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886-895.
12. Doyle MP, Pickering RA, DeWeert TM, et al. Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem. 1981;256:12393-12398.
13. Gladwin MT, Schechter AN. NO contest; nitrite versus S-nitrosohemoglobin. Circ Res. 2004;94:851-855.
14. Lauer T, Preik M, Rassaf T, et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci USA. 2001;98:12814-12819.
15. Kelm M, Preik-Steinhoff H, Preik M, et al. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway. Cardiovasc Res. 1999;41:765-772.
16. Kleinbongard P, Dejam A, Lauer T, et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med. 2003;35:790-796.
17. Dejam A, Hunter CJ, Schechter AN, et al. Emerging role of nitrite in human biology. Blood Cells Mol Dis. 2004;32:423-429.
18. Bryan NS, Rassaf T, Maloney RE, et al. Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc Natl Acad Sci USA. 2004;101:4308-4313.
19. Janero DR, Bryan NS, Saijo F, et al. Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo. Proc Natl Acad Sci USA. 2004;101:16958-16963.
20. Kelm M. Nitric oxide metabolism and breakdown. Biochim Biophys Acta. 1999;1411:273-289.
21. Tannenbaum SR, Witter JP, Gatley SJ, et al. Nitrate and nitrite: origin in humans. Science. 1979;205:1333-1337.
22. Stamler JS, Jaraki O, Osborne J, et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA. 1992;89:7674-7677.
23. Rassaf T, Kleinbongard P, Preik M, et al. Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical study on the fate of NO in human blood. Circ Res. 2002;91:470-477.
24. Langford EJ, Brown AS, Wainwright RJ, et al. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet. 1994;344:1458-1460.
25. Kaposzta Z, Martin JF, Markus HS. Switching off embolization from symptomatic carotid plaque using S-nitrosoglutathione. Circulation. 2002;105:1480-1484.
26. Hallström S, Gasser H, Neumayer C, et al. S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation. 2002;105:3032-3038.
27. Rassaf T, Bryan NS, Kelm M, et al. Concomitant presence of N-nitroso and S-nitroso proteins in human plasma. Free Radic Biol Med. 2002;33:1590-1596.
28. Wang X, Tanus-Santos JE, Reiter CD, et al. Biological activity of nitric oxide in the plasmatic compartment. Proc Natl Acad Sci USA. 2004;101:11477- 11482.
29. Lundberg JO, Weitzberg E. NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol. 2005;25:915-922.
30. Baker PR, Schopfer FJ, Sweeney S, et al. Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proc Natl Acad Sci USA. 2004;101:11577-11582.
31. Rossi R, Giustarini D, Milzani A, et al. Physiological levels of s-nitrosothiols in human plasma. Circ Res. 2001;89:E47.
32. Cannon III RO, Schechter AN, Panza JA, et al. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest. 2001;108:279-287.
33. Feelisch M, Rassaf T, Mnaimneh S, et al. Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. FASEB J. 2002;16:1775-1785.
34. Foster MW. Role of Circulating S-Nitrosothiols in Control of Blood Pressure. Hypertension. 2005;45:15-17.
35. Lundberg JO, Govoni M. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol Med. 2004;37:395-400.
36. Lancaster jr JR. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA. 1994;91:8137-8141.
37. Stamler JS, Jia L, Eu JP, et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 1997;276:2034-2037.
38. Han TH, Qamirani E, Nelson AG, et al. Regulation of nitric oxide consumption by hypoxic red blood cells. Proc Natl Acad Sci USA. 2003;100:12504-12509.
39. Liao JC, Hein TW, Vaughn MW, et al. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci USA. 1999;96:8757-8761.
40. Cosby K, Partovi KS, Crawford JH, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003;9:1498-1505.
41. Liu X, Samouilov A, Lancaster jr JR, et al. Nitric oxide uptake by erythrocytes is primarily limited by extracellular diffusion not membrane resistance. J Biol Chem. 2002;277:26194-26199.
42. Huang K-T, Han TH, Hyduke DR, et al. Modulation of nitric oxide bioavailability by erythrocytes. Proc Natl Acad Sci USA. 2001;98:11771-11776.
43. Vaughn MW, Huang K-T, Kuo L, et al. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem. 2000;275:2342-2348.
44. Coin JT, Olson JS. The rate of oxygen uptake by human red blood cells. J Biol Chem. 1979;254:1178-1190.
45. Kleinbongard P, Schulz R, Rassaf T, et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood. 2006;107:2943-2951.
46. Tsuda K, Kimura K, Nishio I, et al. Nitric oxide improves membrane fluidity of erythrocytes in essential hypertension: an electron paramagnetic resonance investigation. Biochem Biophys Res Commun. 2000;275:946-954.
47. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;409:622-626.
48. Duffy SJ, Keaney jr JF, Holbrook M, et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation. 2001;104:151-156.
49. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339:1523-1526.
50. Hammerstone JF, Lazarus SA, Schmitz HH. Procyanidin content and variation in some commonly consumed foods. J Nutr. 2000;130:2086S-2092S.
51. Rice-Evans C, Miller NJ, Paganga G. Antioxidant properties of polyphenolic compounds. Trends Plant Sci. 1997;2:152-159.
52. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modification of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
53. Brown JE, Khodr H, Hider RC, et al. Structural dependence of flavanoid interactions with Cu2+ ions: implications for their antioxidant properties. Biochem J. 1998;330:1173-1178.
54. Fuhrmann B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr. 1995;61:549-554.
55. Caccetta RA, Croft KD, Beilin LJ, et al. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am J Clin Nutr. 2000;71:67-74.
56. Fisher NDL, Hughes M, Gerhard-Herman M, et al. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens. 2003;21:2281-2286.
57. Karim M, McCormick K, Kappagoda CT. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr. 2000;130:2105S-2108S.
58. Heiss C, Dejam A, Kleinbongard P, et al. Vascular effects of cocoa rich in flavan-3-ols. JAMA. 2003;290:1030-1031.
59. Heiss C, Kleinbongard P, Dejam A, et al. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol. 2005;46:1276-1283.
60. Benito S, Lopez D, Saiz MP, et al. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol. 2002;135:910-916.
61. Wallerath T, Poleo D, Li H, et al. Red wine increases the expression of human endothelial nitric oxide synthase. J Am Coll Cardiol. 2003;41:471-478.